Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
4.420
+0.040 (0.91%)
At close: Mar 20, 2026, 4:00 PM EDT
4.550
+0.130 (2.94%)
After-hours: Mar 20, 2026, 7:59 PM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $68.4 million as of March 20, 2026. Its market cap has increased by 149.62% in one year.
Market Cap
68.40M
Enterprise Value
49.72M
1-Year Change
149.62%
Ranking
Category
Stock Price
$4.42
Market Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $68.40M, a decrease of -99.00%. That is a compound annual growth rate of -33.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 68.40M | 39.88% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 75.73M |
| Annovis Bio | 73.72M |
| XBiotech | 72.87M |
| iBio, Inc. | 72.20M |
| Gain Therapeutics | 70.39M |
| Coeptis Therapeutics Holdings | 70.32M |
| InflaRx | 67.96M |
| Pelthos Therapeutics | 67.11M |